Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher L Corless

Showing results (201-210 of 208) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 208 results.
Nature Communications|March 9, 2017
MAX inactivation is an early event in GIST development that regulates p16 and cell proliferationInga-Marie Schaefer, Yuexiang Wang, Cher-Wei Liang, et al.
Urologic Oncology|September 13, 2015
Neoadjuvant dasatinib for muscle-invasive bladder cancer with tissue analysis of biologic activityNoah M Hahn, Beatrice S Knudsen, Siamak Daneshmand, et al.
NPJ Precision Oncology|October 20, 2021
Multiomics analysis of serial PARP inhibitor treated metastatic TNBC inform on rational combination therapiesMarilyne Labrie, Allen Li, Allison Creason, et al.
Scientific Reports|June 4, 2016
IGF1R as a Key Target in High Risk, Metastatic MedulloblastomaMatthew N Svalina, Ken Kikuchi, Jinu Abraham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 19, 2013
Imatinib for melanomas harboring mutationally activated or amplified KIT arising on mucosal, acral, and chronically sun-damaged skinF Stephen Hodi, Christopher L Corless, Anita Giobbie-Hurder, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 23, 2007
NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)--update of the NCCN clinical practice guidelinesGeorge D Demetri, Robert S Benjamin, Charles D Blanke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 30, 2021
Location of Gastrointestinal Stromal Tumor (GIST) in the Stomach Predicts Tumor Mutation Profile and Drug SensitivityAshwyn K Sharma, Jorge de la Torre, Nikki S IJzerman, et al.
Biorxiv : the Preprint Server for Biology|December 25, 2025
A window trial in metastatic pancreatic ductal adenocarcinoma reveals resistance mechanisms to targeting the KRAS-MEK pathwayMotoyuki Tsuda, Dove Keith, Colin J Daniel, et al.
Pageof 21

Showing results (201-210 of 208) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 208 results.
Nature Communications|March 9, 2017
MAX inactivation is an early event in GIST development that regulates p16 and cell proliferationInga-Marie Schaefer, Yuexiang Wang, Cher-Wei Liang, et al.
Urologic Oncology|September 13, 2015
Neoadjuvant dasatinib for muscle-invasive bladder cancer with tissue analysis of biologic activityNoah M Hahn, Beatrice S Knudsen, Siamak Daneshmand, et al.
NPJ Precision Oncology|October 20, 2021
Multiomics analysis of serial PARP inhibitor treated metastatic TNBC inform on rational combination therapiesMarilyne Labrie, Allen Li, Allison Creason, et al.
Scientific Reports|June 4, 2016
IGF1R as a Key Target in High Risk, Metastatic MedulloblastomaMatthew N Svalina, Ken Kikuchi, Jinu Abraham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 19, 2013
Imatinib for melanomas harboring mutationally activated or amplified KIT arising on mucosal, acral, and chronically sun-damaged skinF Stephen Hodi, Christopher L Corless, Anita Giobbie-Hurder, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 23, 2007
NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)--update of the NCCN clinical practice guidelinesGeorge D Demetri, Robert S Benjamin, Charles D Blanke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 30, 2021
Location of Gastrointestinal Stromal Tumor (GIST) in the Stomach Predicts Tumor Mutation Profile and Drug SensitivityAshwyn K Sharma, Jorge de la Torre, Nikki S IJzerman, et al.
Biorxiv : the Preprint Server for Biology|December 25, 2025
A window trial in metastatic pancreatic ductal adenocarcinoma reveals resistance mechanisms to targeting the KRAS-MEK pathwayMotoyuki Tsuda, Dove Keith, Colin J Daniel, et al.
Pageof 21